T1	AdverseReaction 84 89	DEATH
T2	AdverseReaction 206 211	death
T6	AdverseReaction 439 445	deaths
T7	AdverseReaction 966 971	DEATH
T11	AdverseReaction 1130 1135	death
T12	AdverseReaction 1276 1282	deaths
T14	AdverseReaction 1380 1385	death
T15	Factor 1357 1361	risk
T4	AdverseReaction 45 50	DEATH
T5	DrugClass 97 150	L    ong-acting beta    2    -adrenergic agonist    s
T8	DrugClass 160 164	LABA
T9	DrugClass 303 347	long-acting beta    2    -adrenergic agonist
T13	DrugClass 1049 1086	Long-acting beta2-adrenergic agonists
T16	DrugClass 1088 1092	LABA
T17	DrugClass 1189 1225	long-acting beta2-adrenergic agonist
E1	AdverseReaction:T1
E2	AdverseReaction:T2 Hypothetical2:E5 Hypothetical3:E8
E6	AdverseReaction:T6 Hypothetical:E9
E7	AdverseReaction:T7
E11	AdverseReaction:T11 Hypothetical2:E16 Hypothetical3:E13
E12	AdverseReaction:T12 Hypothetical:E17
E14	AdverseReaction:T14 Hypothetical:E15
E15	Factor:T15
E4	AdverseReaction:T4
E5	DrugClass:T5
E8	DrugClass:T8
E9	DrugClass:T9
E13	DrugClass:T13
E16	DrugClass:T16
E17	DrugClass:T17
A1	CUI E1 C1306577
A2	UMLS-Preferred-Name E1 Death (finding)
A3	MEDDRA-PT E1 Death
A4	MEDDRA-PT-ID E1 10011906
A5	CUI E2 C1306577
A6	UMLS-Preferred-Name E2 Death (finding)
A7	MEDDRA-PT E2 Death
A8	MEDDRA-PT-ID E2 10011906
A9	CUI E6 C1306577
A10	UMLS-Preferred-Name E6 Death (finding)
A11	MEDDRA-PT E6 Death
A12	MEDDRA-PT-ID E6 10011906
A13	CUI E7 C1306577
A14	UMLS-Preferred-Name E7 Death (finding)
A15	MEDDRA-PT E7 Death
A16	MEDDRA-PT-ID E7 10011906
A17	CUI E11 C1306577
A18	UMLS-Preferred-Name E11 Death (finding)
A19	MEDDRA-PT E11 Death
A20	MEDDRA-PT-ID E11 10011906
A21	CUI E12 C1306577
A22	UMLS-Preferred-Name E12 Death (finding)
A23	MEDDRA-PT E12 Death
A24	MEDDRA-PT-ID E12 10011906
A25	CUI E14 C1306577
A26	UMLS-Preferred-Name E14 Death (finding)
A27	MEDDRA-PT E14 Death
A28	MEDDRA-PT-ID E14 10011906
A29	CUI E4 C1306577
A30	UMLS-Preferred-Name E4 Death (finding)
A31	MEDDRA-PT E4 Death
A32	MEDDRA-PT-ID E4 10011906
